DIGITAL EDITION

ARCHIVES

Category: Psychiatry

Defining a Clinically Meaningful Effect for the Design and Interpretation of Randomized Controlled Trials

by Richard S. E. Keefe, PhD; Helena C. Kraemer, PhD; Robert S. Epstein, MD, MS; Ellen Frank, PhD; Ginger Haynes, PhD; Thomas P. Laughren, MD; James McNulty, AbScB; Shelby D.

How Can Registries Contribute to the Development and Evaluation of CNS Therapeutics?

by Joanne B. Severe, MS, and Annette Stemhagen, DrPH, FISPE Ms. Severe is a research consultant in Rockville, Maryland, and Dr. Stemhagen is with United Biosource Corp. in Bethesda, Maryland.

Poverty and Language Development: Roles of Parenting and Stress

by Suzanne C. Perkins, Eric D. Finegood, and James E. Swain Dr. Perkins is from Department of Psychiatry, Faculty of Medicine, University of Michigan, Ann Arbor, Michigan; Mr. Finegood is

Psychiatry in the Ukraine

by Steven D. Targum, Oleh Chaban, and Serhiy Mykhnyak Steven D. Targum, MD, is the scientific director at Clintara LLC, the chief medical officer at Methylation Sciences Inc., BrainCells Inc.,

CNS Sites Cooperate to Detect Duplicate Subjects with a Clinical Trial Subject Registry

by Thomas M. Shiovitz, MD; Charles S. Wilcox, PhD, MPA, MBA; Lilit Gevorgyan, BS; and Adnan Shawkat, BA Dr. Shiovitz is from CTSdatabase, LLC, in Beverly Hills, California and California

Letter to the Editor—“Meow Meow” (Mephedrone) and Catatonia

Venkata Kolli, MBBS; Asish Sharma, MD; Mojgan Amani, MD; Durga Bestha, MBBS, Rajeev Chaturvedi, MBBS Dr. Kolli is Resident,Creighton-Nebraska Psychiatry Residency Program, Omaha, Nebraska; Dr. Sharma is Associate Professor, Department